Back to Agenda
LS28: Issues in Handling of Cartagena Type 1 Use Regulations for Simultaneous International Development of Gene Therapy Drugs
Session Chair(s)
Masafumi Onodera, MD, PhD
Director, Center of Gene Cell Therapy Promotion,
National Center for Child Health and Development, Japan
Speaker(s)
Toshiyuki Nagao
MSD K.K., Japan
Director, Regulatory Affairs Area, Japan Development
Akira Sakurai, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Senior scientist for biopharmaceutical quality
Have an account?